Biggest IPOs this year lose investors money as AI frenzy fades
An FT analysis finds the 10 biggest Wall Street IPOs of 2026 are down on average 20.5% from their offer prices. In each of the previous four years, buying the 10 biggest IPOs would have been in the money by year-end, even in 2022, when the S&P 500 fell 19.4%. That is despite US IPO deal value in 2026 being the highest this decade. SpaceX, the year's biggest listing, soared on debut then sank back and has traded around its $135 offer price for much of the past month. The test now is Anthropic, expected to list this week: it is marketing 825mn shares at $70-$78, which would value it at up to $1.4tn, and bankers are considering raising the price after heavy demand. Fund managers point to heavy bond and equity issuance ('a bit of fatigue', LGT Wealth Management CIO Sanjay Rijhsinghani), to IPOs not coming at 'bargain-basement prices', and to an October chip-stock sell-off that deepened after the US midterms (a Democratic sweep with anti-data-centre platforms), though the Nasdaq 100 has recovered most of those losses. Federated Hermes' John Ettinger says more big deals are down a lot this year than at any point in his career; an unnamed senior asset-manager executive calls the class of 2026 'awful' and says a bad Anthropic deal 'could screw up my entire year'. Some investors say they would rather buy later in the secondary market, but few want to miss Anthropic. Caveats: US listings only; the per-company list sits in a chart that is not itemised in the text; SpaceX is roughly flat against its offer price rather than down; and post-IPO underperformance is common (lock-up expiries), just worse this year.
Why it matters
This is the public-market exit window that late-stage valuations in Dealroom depend on, and it is weakening just as the biggest AI company tries to list. If the largest 2026 IPOs are under water on average, crossover and late-stage investors will price private rounds and secondaries more cautiously, and European scale-ups eyeing a US listing face a tougher bar. Anthropic's pricing and first weeks of trading this week will set the tone for AI-lab and AI-infrastructure valuations, including the private comparables in Dealroom.
Executive takeaways
1) The 10 biggest US IPOs of 2026 are down 20.5% on average from offer, breaking a four-year run in which the top-10 basket ended each year in the money, even in 2022. 2) Record deal value has not meant good returns: investors cite issuance fatigue and full pricing. 3) SpaceX, the year's biggest IPO, is trading around its $135 offer price after an early spike, so it is flat rather than down. 4) Anthropic (825mn shares at $70-$78, up to $1.4tn) lists this week into this backdrop, with demand strong enough that bankers are weighing a higher price; investors call it the first pure-play AI stock. 5) The October chip sell-off and post-midterm data-centre politics are part of the backdrop, though the Nasdaq 100 has recovered most losses.
What Financial Times may be missing
The text does not name the 10 IPOs, their offer prices, exchanges or the date the returns were measured; those sit in an un-itemised chart, so it is unclear how much a few names drive the average. It is US-only, with no read-across to European or Asian listings or to how the 2026 class compares with the broader IPO index. It does not separate AI from non-AI listings, so the 'AI frenzy fades' framing is inferred rather than shown. It gives no data on lock-up expiries, secondary-market discounts or what this means for private late-stage valuations, and the Anthropic terms may still change before pricing.